Only some doses of Trevena’s experimental opioid painkiller were found as effective as morphine in two late-stage studies, though the drug met its main study goals.

Amphastar Pharmaceuticals Inc. said the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose treatment, naloxone.

Amygdala Neurosciences has agreed to acquire Gilead’s GS-6637, a highly selective ALDH2 inhibitor with the potential to treat behavior and substance addictions.

The U.S. Food and Drug Administration approved Egalet Corp.’s Arymo ER and will allow the company to claim the long-acting opioid painkiller deters abuse by those seeking to dissolve and inject it.

Partnership for Drug-Free Kids announced the national launch of “Search and Rescue,” a prescriber education campaign that gives healthcare providers the resources they need to prescribe opioids responsibly and prevent the misuse and abuse of medicine in their practices.

A U.S. advisory panel recommended approval of Pfizer Inc’s long-acting opioid painkiller Troxyca ER, saying it dulls pain and its design could deter abuse by addicts in search of a quick high.

Titan Pharmaceuticals announced that the U.S. FDA approved Probuphine (buprenorphine) implant for long-term maintenance of opioid dependence.

With a nod to his own drug use as a young man, President Barack Obama on Tuesday called for more funding and a new approach to help people addicted to heroin and prescription drugs, seeking to shine a public spotlight on an increasingly deadly killer. During an appearance at a drug abuse summit in Atlanta, […]

At least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso’s new mental-health initiative.   New York City’s Department of Health and Mental Hygiene expects to release the plan, known as NYC […]